Company Filing History:
Years Active: 2013
Title: Annette Dalrymple: Innovator in Huntington's Disease Diagnosis
Introduction
Annette Dalrymple is a notable inventor based in London, GB. She has made significant contributions to the field of medical diagnostics, particularly in relation to Huntington's disease. Her innovative work has led to the development of methods that can aid in the early detection of this neurodegenerative disorder.
Latest Patents
Annette holds a patent for her invention titled "Methods and compositions for monitoring progression of Huntington's disease." This patent describes a method of diagnosing Huntington's disease by detecting altered concentrations of specific proteins in a diagnostic sample taken from a human subject. The proteins involved in this diagnostic process include Clusterin precursor, Haptoglobin precursor, and several others, which are crucial for understanding the progression of the disease.
Career Highlights
Annette is currently associated with Electrophoretics Limited, where she continues to advance her research and innovations. Her work has been instrumental in developing diagnostic tools that can significantly impact patient care and treatment options for those affected by Huntington's disease.
Collaborations
Throughout her career, Annette has collaborated with esteemed colleagues, including Nicola Louise Leeds and Malcolm Andrew Ward. These partnerships have fostered a collaborative environment that enhances the research and development of innovative diagnostic methods.
Conclusion
Annette Dalrymple's contributions to the field of Huntington's disease diagnostics exemplify her dedication to medical innovation. Her work not only highlights the importance of early detection but also showcases the potential for advancements in patient care.